Artia Global Partners as of June 30, 2026
Portfolio Holdings for Artia Global Partners
Artia Global Partners holds 48 positions in its portfolio as reported in the June 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Abivax Sa Sponsored Ads (ABVX) | 12.7 | $69M | 516k | 133.26 | |
| Insmed Com Par $.01 (INSM) | 11.6 | $63M | 589k | 106.62 | |
| Trevi Therapeutics (TRVI) | 7.6 | $41M | 2.2M | 18.65 | |
| Brightspring Health Svcs (BTSG) | 6.7 | $36M | 517k | 69.74 | |
| Revolution Medicines (RVMD) | 6.4 | $35M | 185k | 187.28 | |
| Argenx Se Sponsored Adr (ARGX) | 5.1 | $28M | 30k | 927.77 | |
| Alkermes SHS (ALKS) | 4.3 | $24M | 449k | 52.40 | |
| Travere Therapeutics (TVTX) | 3.6 | $19M | 339k | 56.81 | |
| Astrazeneca Ord (AZN) | 3.4 | $19M | 98k | 189.62 | |
| Newamsterdam Pharma Company Ordinary Shares (NAMS) | 3.2 | $17M | 504k | 33.89 | |
| Dianthus Therapeutics (DNTH) | 2.9 | $16M | 163k | 97.48 | |
| Spdr Series Trust St Str Sp Biot (XBI) | 2.9 | $16M | 100k | 158.25 | |
| Quest Diagnostics Incorporated (DGX) | 2.5 | $14M | 65k | 211.95 | |
| Ionis Pharmaceuticals (IONS) | 2.1 | $11M | 144k | 79.29 | |
| Eyepoint Com New (EYPT) | 2.0 | $11M | 767k | 14.30 | |
| Alumis (ALMS) | 1.4 | $7.8M | 279k | 28.14 | |
| Viking Therapeutics (VKTX) | 1.3 | $7.1M | 181k | 39.01 | |
| Celcuity (CELC) | 1.1 | $6.2M | 59k | 104.62 | |
| Cytokinetics Com New (CYTK) | 1.1 | $6.0M | 71k | 85.19 | |
| Merck & Co (MRK) | 1.1 | $6.0M | 47k | 128.50 | |
| Rapport Therapeutics (RAPP) | 1.1 | $5.8M | 139k | 41.67 | |
| Johnson & Johnson (JNJ) | 1.1 | $5.7M | 23k | 253.97 | |
| Guardant Health (GH) | 1.1 | $5.7M | 38k | 150.03 | |
| Absci Corp (ABSI) | 1.0 | $5.4M | 464k | 11.59 | |
| Scholar Rock Hldg Corp (SRRK) | 1.0 | $5.3M | 96k | 55.00 | |
| Sionna Therapeutics (SION) | 1.0 | $5.3M | 120k | 43.99 | |
| Ascendis Pharma A/s Ord Shs (ASND) | 0.9 | $4.7M | 18k | 266.72 | |
| Roivant Sciences SHS (ROIV) | 0.8 | $4.6M | 130k | 35.39 | |
| Palisade Bio (PALI) | 0.8 | $4.2M | 2.0M | 2.09 | |
| Edgewise Therapeutics (EWTX) | 0.7 | $4.0M | 99k | 40.63 | |
| Biogen Idec (BIIB) | 0.7 | $4.0M | 18k | 216.06 | |
| Xenon Pharmaceuticals (XENE) | 0.7 | $3.9M | 65k | 60.36 | |
| Belite Bio Sponsored Ads (BLTE) | 0.7 | $3.8M | 25k | 153.99 | |
| Mineralys Therapeutics (MLYS) | 0.7 | $3.7M | 138k | 26.98 | |
| Prokidney Corp Shs Cl A (PROK) | 0.7 | $3.7M | 1.8M | 2.04 | |
| Enliven Therapeutics (ELVN) | 0.7 | $3.7M | 72k | 50.75 | |
| Oruka Therapeutics (ORKA) | 0.6 | $3.2M | 33k | 95.17 | |
| Protagonist Therapeutics (PTGX) | 0.5 | $2.8M | 23k | 122.58 | |
| United Therapeutics Corporation (UTHR) | 0.5 | $2.7M | 5.0k | 541.83 | |
| Bright Minds Biosciences Com New (DRUG) | 0.5 | $2.7M | 38k | 70.20 | |
| Kiniksa Pharmaceuticals Intl Ord Shs Cl A (KNSA) | 0.3 | $1.9M | 29k | 63.95 | |
| Compass Therapeutics (CMPX) | 0.2 | $839k | 383k | 2.19 | |
| Praxis Precision Medicines I Com New (PRAX) | 0.2 | $837k | 2.5k | 334.79 | |
| Kodiak Sciences (KOD) | 0.1 | $663k | 17k | 38.96 | |
| Tenax Therapeutics Com New (TENX) | 0.1 | $612k | 42k | 14.55 | |
| Nuvalent Inc-a (NUVL) | 0.1 | $605k | 4.9k | 123.50 | |
| Pepgen (PEPG) | 0.1 | $370k | 205k | 1.80 | |
| Spyre Therapeutics Com New (SYRE) | 0.1 | $355k | 4.0k | 88.78 |
